Palatin Technologies (PTN) EV to EBITDA (2010 - 2026)
Palatin Technologies' (PTN) quarterly EV to EBITDA came in at 36.68 in Q1 2026, down 1283.52% on a YoY basis from 3.1 in Q1 2025, and down 993.39% quarter-over-quarter from 3.35 in Q4 2025.
Analysis
Palatin Technologies (PTN) EV to EBITDA (2010 - 2026) Analysis & Trends
Palatin Technologies (PTN) has reported EV to EBITDA for 17 consecutive years, with 36.68 the latest figure, recorded in Q1 2026.
- For the quarter ending Q1 2026, EV to EBITDA fell 1283.52% year-over-year to 36.68; the trailing twelve-month figure through Mar 2026 stood at 8.89 (down 1540.33% YoY), and the FY2025 full-year result was 5.75, up 90.92% from the prior year.
- EV to EBITDA retreated to 36.68 in Q1 2026 per PTN's latest filing, from 3.35 in the prior quarter.
- Across five years, EV to EBITDA topped out at 2418.49 in Q4 2023 and bottomed at 17036.46 in Q1 2022.
- Historically, EV to EBITDA has averaged 2325.65 across 5 years, with a median of 144.01 in 2024.
- The sharpest annual moves came in 2023 and 2026: EV to EBITDA surged 145.58% in 2023, then slumped 1283.52% in 2026.
- Over 5 years, EV to EBITDA stood at 5306.36 in 2022, then surged by 145.58% to 2418.49 in 2023, then sank by 120.56% to 497.21 in 2024, then jumped by 99.33% to 3.35 in 2025, then sank by 993.39% to 36.68 in 2026.
- According to Business Quant data, EV to EBITDA over the past three periods registered 36.68, 3.35, and 1.38 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Palatin Technologies | 46.98 Mn | 46.98 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -36.68 |
| Dec 31, 2025 | -3.35 |
| Sep 30, 2025 | 1.38 |
| Jun 30, 2025 | -0.49 |
| Mar 31, 2025 | -2.65 |
| Dec 31, 2024 | -497.21 |
| Sep 30, 2024 | -111.72 |
| Jun 30, 2024 | -170.63 |
| Mar 31, 2024 | -144.01 |
| Dec 31, 2023 | 2,418.49 |
| Sep 30, 2023 | -146.74 |
| Jun 30, 2023 | -112.12 |
| Mar 31, 2023 | -4,362.16 |
| Dec 31, 2022 | -5,306.36 |
| Sep 30, 2022 | -7,835.76 |
| Jun 30, 2022 | -6,189.63 |
| Mar 31, 2022 | -17,036.46 |
| Dec 31, 2021 | -17,471.91 |
| Sep 30, 2021 | -17,622.89 |
| Jun 30, 2021 | -12,796.92 |